Arbutus Biopharma (ABUS) Non Operating Investment Income (2018)
Arbutus Biopharma's (ABUS) quarterly Non Operating Investment Income came in at $24.9 million in Q2 2018.
Arbutus Biopharma (ABUS) Non Operating Investment Income (2018) Analysis & Trends
Arbutus Biopharma has disclosed Non Operating Investment Income across 1 years of filings, most recently posting $24.9 million for Q2 2018.
- Non Operating Investment Income for Q2 2018 came in at $24.9 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2019 was $24.9 million (changed 0.0% YoY), and the FY2018 annual result was $24.9 million, changed N/A from the prior year.
- Non Operating Investment Income came in at $24.9 million for Q2 2018 at Arbutus Biopharma.
- In the past five years, Non Operating Investment Income ranged from a high of $24.9 million in Q2 2018 to a low of $24.9 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 24.88 Mn |
| Jun 30, 2018 | 24.88 Mn |